Literature DB >> 1383490

Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat.

A N Fisher1, L Illum, S S Davis, E H Schacht.   

Abstract

A series of fractionated di-iodo-L-tyrosine-labelled dextrans (DIT dextrans), with a narrow range of number average molecular weights from 1260 to 45,500 Da, was administered intranasally and intravenously to anaesthetized rats. The nasal absorption of these compounds ranged from 0.6 to 52.7%. There was an inverse relationship between molecular size and the proportion of an intranasal dose absorbed. The study demonstrated the usefulness of DIT dextrans as molecular weight markers and confirmed the relationship between molecular size and nasal absorption for highly water soluble compounds. These results also supported the proposition that there is a continuous range of aqueous pores in the nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383490     DOI: 10.1111/j.2042-7158.1992.tb05462.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.

Authors:  E Marttin; J C Verhoef; C Cullander; S G Romeijn; J F Nagelkerke; F W Merkus
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

2.  Insoluble powder formulation as an effective nasal drug delivery system.

Authors:  Fusashi Ishikawa; Mika Murano; Minoru Hiraishi; Toshikazu Yamaguchi; Ikumi Tamai; Akira Tsuji
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

3.  Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.

Authors:  Kristian P Doyle; Tao Yang; Nikola S Lessov; Thomas M Ciesielski; Susan L Stevens; Roger P Simon; Jeffrey S King; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-26       Impact factor: 6.200

4.  Permeabilization of the blood-brain barrier via mucosal engrafting: implications for drug delivery to the brain.

Authors:  Benjamin S Bleier; Richie E Kohman; Rachel E Feldman; Shreshtha Ramanlal; Xue Han
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 5.  Bypassing the blood-brian barrier using established skull base reconstruction techniques.

Authors:  Marcel M Miyake; Benjamin S Bleier
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2015-10-23

6.  Spray Freeze Dried Lyospheres® for Nasal Administration of Insulin.

Authors:  Tuğrul Mert Serim; Jan Kožák; Annika Rautenberg; Ayşe Nurten Özdemir; Yann Pellequer; Alf Lamprecht
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.